The prognostic value of the suPARnostic® ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms
2007

Prognostic Value of suPAR in HIV-1 Patients

Sample size: 145 publication Evidence: high

Author Information

Author(s): Uffe V. Schneider, Rikke L. Nielsen, Court Pedersen, Jesper Eugen-Olsen

Primary Institution: Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark

Hypothesis

Elevated plasma suPAR levels indicate a heightened inflammatory state.

Conclusion

Plasma suPAR levels are strong predictors of survival in ART-naïve HIV-1 infected patients and are not influenced by uPAR promoter polymorphisms.

Supporting Evidence

  • Survival was strongly correlated to suPAR levels.
  • Patients with suPAR levels at or above 6 ng/ml had a higher mortality rate.
  • The study identified two common uPAR promoter polymorphisms that did not influence suPAR levels or survival.

Takeaway

This study found that high levels of a protein called suPAR can help predict how long HIV patients might live, and that certain genetic changes don't affect this prediction.

Methodology

DNA and plasma samples were collected from HIV-1 infected individuals, and survival was analyzed using Kaplan Meier analysis.

Limitations

The study had a small sample size for some analyses, which may limit the generalizability of the findings.

Participant Demographics

145 HIV-1 infected Caucasians, 122 males with a mean seroconversion age of 32.0 years and 23 females with a mean age of 40.2 years.

Statistical Information

P-Value

p < 0.001

Statistical Significance

p < 0.001

Digital Object Identifier (DOI)

10.1186/1471-2334-7-134

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication